Ann: Activities Update Qtr Ending June 2023 and Appendix 4C, page-8

we are talking about a 12m mc company, that is expanding its sales into multiple regions over the world, and rattling the keys into the door of a massive Chinese market.
Has a real product, that has superior outcomes for patient, is betting on expanding market penetration.
Markets will continue to back, and support this as it is putting runs on the board.
Many companies require that support, as they transition to cash flow positive.

The China door being opened, will potentially make enough noise, to get this moving. Was so, before the CR flippers subdued the price momentum.

There are plenty of irons in the fire, globally speaking for sales growth to continue.